1. Home
  2. STAA vs DFIN Comparison

STAA vs DFIN Comparison

Compare STAA & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • DFIN
  • Stock Information
  • Founded
  • STAA 1982
  • DFIN 1983
  • Country
  • STAA United States
  • DFIN United States
  • Employees
  • STAA N/A
  • DFIN N/A
  • Industry
  • STAA Ophthalmic Goods
  • DFIN Other Consumer Services
  • Sector
  • STAA Health Care
  • DFIN Consumer Discretionary
  • Exchange
  • STAA Nasdaq
  • DFIN Nasdaq
  • Market Cap
  • STAA 1.6B
  • DFIN 1.9B
  • IPO Year
  • STAA N/A
  • DFIN N/A
  • Fundamental
  • Price
  • STAA $28.44
  • DFIN $62.23
  • Analyst Decision
  • STAA Buy
  • DFIN Strong Buy
  • Analyst Count
  • STAA 7
  • DFIN 3
  • Target Price
  • STAA $43.33
  • DFIN $76.33
  • AVG Volume (30 Days)
  • STAA 654.9K
  • DFIN 219.5K
  • Earning Date
  • STAA 10-30-2024
  • DFIN 10-31-2024
  • Dividend Yield
  • STAA N/A
  • DFIN N/A
  • EPS Growth
  • STAA 9.97
  • DFIN 18.18
  • EPS
  • STAA 0.44
  • DFIN 3.18
  • Revenue
  • STAA $341,224,000.00
  • DFIN $802,100,000.00
  • Revenue This Year
  • STAA $8.45
  • DFIN $1.75
  • Revenue Next Year
  • STAA $12.35
  • DFIN $4.27
  • P/E Ratio
  • STAA $64.91
  • DFIN $19.80
  • Revenue Growth
  • STAA 10.01
  • DFIN 1.74
  • 52 Week Low
  • STAA $26.66
  • DFIN $55.64
  • 52 Week High
  • STAA $52.68
  • DFIN $71.01
  • Technical
  • Relative Strength Index (RSI)
  • STAA 39.29
  • DFIN 48.14
  • Support Level
  • STAA $29.56
  • DFIN $56.02
  • Resistance Level
  • STAA $32.00
  • DFIN $65.36
  • Average True Range (ATR)
  • STAA 1.53
  • DFIN 2.14
  • MACD
  • STAA -0.00
  • DFIN 0.36
  • Stochastic Oscillator
  • STAA 16.82
  • DFIN 66.49

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a global risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( US), Europe, Asia, Canada, and others, of which the US accounts for the vast majority of its total revenue.

Share on Social Networks: